Cumberland Pharmaceuticals (CPIX) Total Debt Growth (1y) (2011 - 2026)
Cumberland Pharmaceuticals (CPIX) Total Debt Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -3.69% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 37.49% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -2.48% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 4.38% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | -6.91% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 41.53% |
| 10 | Cumberland Pharmaceuticals | 114.68 Mn | 110.82 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.00% |
| Dec 31, 2025 | -65.69% |
| Sep 30, 2025 | -67.43% |
| Jun 30, 2025 | -67.43% |
| Mar 31, 2025 | -67.42% |
| Dec 31, 2024 | 19.49% |
| Sep 30, 2024 | 24.52% |
| Jun 30, 2024 | 22.39% |
| Mar 31, 2024 | 0.07% |
| Dec 31, 2023 | -21.09% |
| Sep 30, 2023 | -26.99% |
| Jun 30, 2023 | -30.80% |
| Mar 31, 2023 | -19.64% |
| Dec 31, 2022 | 8.00% |
| Sep 30, 2022 | 18.00% |
| Jun 30, 2022 | 35.71% |
| Mar 31, 2022 | 33.33% |
| Dec 31, 2021 | 0.00% |
| Sep 30, 2021 | -11.76% |
| Jun 30, 2021 | -17.65% |